METTL3 and glioma: Compared to the miR-101 overexpression group, glioma cells co-expressing miR-101 and METTL3 exhibited enhanced proliferation (Fig. 7D), restored p62 protein levels, decreased LC3II expression (Fig. 7E), and suppressed autophagic flux (Fig. 7F).